InvestorsHub Logo

drbio45

06/24/13 6:17 PM

#1191 RE: biocqr #1188

David Allan was appointed chairman after sctpf's drug failed.

David and the ceo of the private company of Trillium Nicklas Stiernolm, worked together in the past, and I guess Nick felt that David had the contacts to bring the story to the US.

I think the science at this company compares favorably with that of Stemline and especially Verastem.